U.S. agency helps fund Takeda effort to develop Zika vaccine

Sep 2, 2016

U.S. agency helps fund Takeda effort to develop Zika vaccine

Japanese drugmaker Takeda Pharmaceutical Co. on Thursday said it is developing a vaccine to prevent the Zika virus, which has been linked to severe birth defects, and has secured funding from a U.S. government agency. Takeda, which is also working on vaccines for other mosquito-borne ...

/ Nov 27, 2014

Ebola vaccine from Glaxo passes early safety test

An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine. The trial, which began ...